Scriptgen Pharmaceuticals Inc.

Scriptgen Pharmaceuticals, Inc. is a leader in the discovery of drugs to control the expression of genes. Current programs in the anti-infective area have identified multiple new drug targets and lead compounds effective against drug-resistant bacterial, fungal and viral pathogens. Scriptgen Pharmaceuticals and the European Molecular Biology Laboratory announce the formation of Anadys Pharmaceuticals, a fully integrated pharmaceutical company that develops novel therapeutics to treat infectious disease. The Company is integrating the latest drug discovery tools and technologies into a seamless platform to rapidly translate breakthroughs in genomics, biology, chemistry, and informatics.
Anadys Pharmaceuticals is a fully integrated pharmaceutical company with capabilities for discovery, development and commercialization of new medicines to treat disease. The initial focus of Anadys is on the creation of new drugs for the treatment of infectious disease. Anadys' drug discovery engine combines cutting edge chemistry and biology with informatics and proprietary affinity high-throughput screening technologies

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Genetics
- Infectious Diseases

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: